Free Trial

McKesson (MCK) Competitors

McKesson logo
$802.17 +9.20 (+1.16%)
Closing price 10/24/2025 03:59 PM Eastern
Extended Trading
$803.10 +0.92 (+0.11%)
As of 10/24/2025 07:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

MCK vs. HOLX, HQY, HSIC, MMSI, AMN, CRL, HUM, ITGR, WST, and COR

Should you be buying McKesson stock or one of its competitors? The main competitors of McKesson include Hologic (HOLX), HealthEquity (HQY), Henry Schein (HSIC), Merit Medical Systems (MMSI), AMN Healthcare Services (AMN), Charles River Laboratories International (CRL), Humana (HUM), Integer (ITGR), West Pharmaceutical Services (WST), and Cencora (COR). These companies are all part of the "medical" sector.

McKesson vs. Its Competitors

McKesson (NYSE:MCK) and Hologic (NASDAQ:HOLX) are both large-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, institutional ownership, valuation, profitability, media sentiment, earnings and dividends.

McKesson has a beta of 0.52, suggesting that its share price is 48% less volatile than the S&P 500. Comparatively, Hologic has a beta of 0.63, suggesting that its share price is 37% less volatile than the S&P 500.

In the previous week, Hologic had 16 more articles in the media than McKesson. MarketBeat recorded 47 mentions for Hologic and 31 mentions for McKesson. McKesson's average media sentiment score of 1.36 beat Hologic's score of 0.70 indicating that McKesson is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
McKesson
24 Very Positive mention(s)
3 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Hologic
20 Very Positive mention(s)
7 Positive mention(s)
12 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

McKesson has higher revenue and earnings than Hologic. Hologic is trading at a lower price-to-earnings ratio than McKesson, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
McKesson$359.05B0.28$3.30B$25.0831.98
Hologic$4.04B4.07$789.50M$2.4130.70

McKesson presently has a consensus target price of $834.54, suggesting a potential upside of 4.03%. Hologic has a consensus target price of $79.23, suggesting a potential upside of 7.08%. Given Hologic's higher probable upside, analysts plainly believe Hologic is more favorable than McKesson.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
McKesson
0 Sell rating(s)
3 Hold rating(s)
13 Buy rating(s)
1 Strong Buy rating(s)
2.88
Hologic
0 Sell rating(s)
13 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.37

Hologic has a net margin of 13.79% compared to McKesson's net margin of 0.84%. Hologic's return on equity of 19.69% beat McKesson's return on equity.

Company Net Margins Return on Equity Return on Assets
McKesson0.84% -196.66% 5.66%
Hologic 13.79%19.69%10.82%

85.1% of McKesson shares are owned by institutional investors. Comparatively, 94.7% of Hologic shares are owned by institutional investors. 0.1% of McKesson shares are owned by company insiders. Comparatively, 1.9% of Hologic shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

Hologic beats McKesson on 9 of the 16 factors compared between the two stocks.

Get McKesson News Delivered to You Automatically

Sign up to receive the latest news and ratings for MCK and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MCK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MCK vs. The Competition

MetricMcKessonMED/DENTAL IndustryMedical SectorNYSE Exchange
Market Cap$98.63B$18.19B$6.23B$22.00B
Dividend Yield0.41%1.63%5.71%3.58%
P/E Ratio31.9818.2530.2033.18
Price / Sales0.282.33590.3461.49
Price / Cash20.4113.3937.0124.54
Price / Book-59.333.0312.044.66
Net Income$3.30B$472.95M$3.32B$1.01B
7 Day Performance1.76%2.53%1.89%2.24%
1 Month Performance8.75%-0.63%7.68%2.10%
1 Year Performance58.09%-10.07%56.01%14.01%

McKesson Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MCK
McKesson
4.5272 of 5 stars
$802.17
+1.2%
$834.54
+4.0%
+58.9%$98.63B$359.05B31.9845,000Positive News
HOLX
Hologic
4.4317 of 5 stars
$71.87
+2.9%
$80.15
+11.5%
-8.6%$15.99B$4.03B29.827,063Analyst Forecast
Insider Trade
HQY
HealthEquity
3.5563 of 5 stars
$93.03
+1.7%
$121.31
+30.4%
+10.2%$8.02B$1.20B56.383,120Positive News
Insider Trade
HSIC
Henry Schein
4.1463 of 5 stars
$63.93
+1.5%
$76.67
+19.9%
-9.9%$7.75B$12.67B20.6225,000Positive News
Analyst Forecast
MMSI
Merit Medical Systems
4.4782 of 5 stars
$83.21
+1.6%
$106.50
+28.0%
-13.7%$4.93B$1.36B42.247,400Positive News
Upcoming Earnings
AMN
AMN Healthcare Services
4.2607 of 5 stars
$19.77
+0.5%
$23.08
+16.8%
-46.3%$757.40M$2.98B-2.542,968News Coverage
Analyst Forecast
Short Interest ↓
CRL
Charles River Laboratories International
4.3069 of 5 stars
$184.10
+3.1%
$181.29
-1.5%
+8.1%$9.06B$4.05B-138.4220,100Analyst Downgrade
HUM
Humana
4.1917 of 5 stars
$283.75
+3.2%
$297.58
+4.9%
+12.5%$34.13B$117.76B21.7865,680Positive News
ITGR
Integer
3.7731 of 5 stars
$107.38
+2.4%
$137.29
+27.9%
-42.5%$3.76B$1.72B47.3011,000Trending News
Earnings Report
Analyst Forecast
WST
West Pharmaceutical Services
4.5891 of 5 stars
$274.71
+1.5%
$321.89
+17.2%
-9.8%$19.75B$2.89B41.1210,600Trending News
Earnings Report
Analyst Forecast
COR
Cencora
4.4613 of 5 stars
$327.56
+0.9%
$324.91
-0.8%
+41.6%$63.51B$293.96B33.7046,000Positive News
Insider Trade

Related Companies and Tools


This page (NYSE:MCK) was last updated on 10/25/2025 by MarketBeat.com Staff
From Our Partners